medigraphic.com
ISSN 1561-3194 (Electronic)

2012, Number 2

<< Back Next >>

Rev Ciencias Médicas 2012; 16 (2)

Reactional leprosy. A case report

Moreira RI, Vázquez RC, Cruz RE, Rivera MA, Mujica GDB

Language: Spanish
References: 9
Page: 226-232
PDF size: 74.64 Kb.


ABSTRACT

Reactional leprosy is a clinical modality of acute and sub-acute presentation which is local or general, expression of an immunological phenomenon that occurs in the natural history of the disease. It can arise in almost the 30% of the multibacillary, lepromatous and dimorphous patients. In this current study a case of forty four-year-old male patient diagnosed as lepromatous leprosy was reported. The patient presented an exacerbated presentation of the clinical chart with disseminated and infiltrated nodules corresponding to a type-2 reactional leprosy and erythema nodosum leprosum.


REFERENCES

  1. Rada E, Nacarid Aranzazu A, Convit J. Ciertos aspectos inmunológicos en los estados reaccionales en la enfermedad de Hansen. Revisión. Invest clín. 2005 dic; 46(4):1-6

  2. Cuevas J, Rodríguez-Peralto JL, Carrillo R, Contreras F. Erythema Nodosum Leprosum: Reactional Leprosy. Seminars in Cutaneous Medicine and Surgery [Internet]. 2007 June [citado 4 del 2011]; 26(2):126-130. [aprox 3] Disponible en: http://www.sciencedirect.com/science/article/pii/S1085562907000119

  3. Olivares L, Pizzariello G, D'Atri G, Martínez A, Casas C, Belén Jalo M, Rodríguez Prados G. Reactional leprosy. Dermatol Argent. 2009; 15(2):125-130.

  4. Kahawita IP, Lockwood DN. Towards understanding the pathology of erythema nodosum leprosum. Transactions of the Royal Society of Tropical Medicine and Hygiene [Internet]. 2008 [citado 3 del 2011]; 102(4):329-37. Disponible en: http://www.sciencedirect.com/science/article/pii/S0035920308000072

  5. Pocaterra L, Jain S, Reddy R, Muzaffarullah S, Torres O, Suneetha S, et al. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. American Journal of Tropical Medicine and Hygiene [Internet]. 2006 [citado 3 del 2011]; 74 (5):868-79. [aprox 4] Disponible en: http://www.ajtmh.org/content/74/5/868.full.pdf+html

  6. Sheetal S, Arvind C. Lest we forget Hansen's disease (leprosy): an unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience. International Journal of Rheumatic Diseases [Internet]. 2009 April [citado 4 del 2011]; 12(1): 64-69. [aprox 4] Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1756-185X.2009.01382.x/pdf

  7. Sales AM, de Matos HJ, Nery JA, Duppre NC, Sampaio EP, Sarno EN. Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy. Revista brasileira de pesquisas médicas e biológicas [Internet]. 2007[citado 4 del 2011]; 40(2): 243-8. [aprox 6] Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2007000200011&lng=en&nrm=iso&tlng=en

  8. Villahermosa LG, Fajardo TT, Abalos RM, Balagon MV, Tan EV, Cellona RV, et al. A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum. The American Journal of Tropical Medicine and Hygiene [Internet]. 2005 [citado 3 del 2011]; 72(5):518-26. [aprox 6] Disponible en: http://www.ajtmh.org/content/72/5/518.full.pdf+html

  9. Walker SL, Waters MF, Lockwood DN. The role of thalidomide in the management of erythema nodosum leprosum. Leprosy Review [Internet]. 2007 [citado4 del 2011]; 78(3):197-215. [aprox 6] Disponible en: http://web.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=cb63a8ba-7d35-4531-beba-c0b391bdbf05%40sessionmgr10&vid=3&hid=125




2020     |     www.medigraphic.com